Influenza B viruses cause significant morbidity and mortality, particularly in children, but the
awareness of their impact is often less than influenza A viruses partly due to their lack of …

Influenza viruses undergo antigenic changes in the immuno-dominant hemagglutinin (HA)
head domain, necessitating annual re-formulation of and re-vaccination with seasonal …

Background The severity of influenza disease can range from mild symptoms to severe
respiratory failure and can partly be explained by host genetic factors that predisposes the …

Background The relationship between early oseltamivir treatment (within 48 h of symptom
onset) and mortality in patients admitted to intensive care units (ICUs) with severe influenza …

Background The severity of an influenza infection is influenced by both host and viral
characteristics. This study aims to assess the relevance of viral genomic data for the …

Influenza B virus (IBV) causes respiratory infectious disease. Cytokines are important
immune mediators during infectious diseases. Cortisol and stress have been related to …

A quarter of all seasonal influenza cases are caused by type B influenza virus (IBV) that also
dominates periodically. Here, we investigated a recombinant adenovirus vaccine carrying a …

Homotypic co-infections with influenza viruses are described to increase genetic population
diversity, to drive viral evolution and to allow genetic complementation. Less is known about …

Background SARS-CoV-2 strains evolve continuously and accumulate mutations in their
genomes over the course of the pandemic. The severity of a SARS-CoV-2 infection could …

Influenza B viruses circulate globally every year causing respiratory disease with significant
clinical and socio-economic impacts. IBV are considered exclusive human pathogens with …